SEARCH

SEARCH BY CITATION

References

  • 1
    Belle SH, Beringer KC, Detre KM, Terasaki PI, Cecka JM. Recent findings concerning liver transplantation in the United States. In: Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory; 1997: 1530.
  • 2
    Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117:619625.MEDLINE
  • 3
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317322.MEDLINE
  • 4
    Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:14631466.MEDLINE
  • 5
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671675.MEDLINE
  • 6
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.MEDLINE
  • 7
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.MEDLINE
  • 8
    Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998; 4:2227.MEDLINE
  • 9
    Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89:13611365.MEDLINE
  • 10
    Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20(suppl):S24S27.
  • 11
    Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62:17731776.MEDLINE
  • 12
    Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:11781182.MEDLINE
  • 13
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203210.MEDLINE
  • 14
    Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia. Hepatology 1996; 24:10411046.MEDLINE
  • 15
    Bellati G, Alberti AB, Belli LS, Vai C, Airoldi A, Rondinara GF, et al. Therapy of chronic hepatitis C after liver transplantation: Multicenter Italian experience [abstract]. J Hepatol 1999; 30(suppl):S51A.
  • 16
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26:500504.MEDLINE
  • 17
    Lavezzo B, Rizzetto M, Smedile A, Ottobrelli A, Ghisetti V, Franchello A, et al. Combination therapy of interferon alfa 2b and ribavirin for recurrent hepatitis C after liver transplantation. J Hepatol 1999; 30:6772.
  • 18
    Shakil AO, McGuire B, Crippin JS, Conjeevaram HS, Teperman L, Gish R, et al. Interferon-alfa 2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C [abstract]. Hepatology 2000; 32:217A.
  • 19
    Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali M, et al. Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination. Transplant Proc 1997; 29:519521.MEDLINE
  • 20
    Kapur A, Rodriguez MJ, Schecter P, Tzakis A, Schiff ER. Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection [abstract]. Gastroenterology 1998; 114:1268A.
  • 21
    Muramatsu S, Ku Y, Fukumoto T, Iwasaki T, Tominaga M, Kusunoki N, et al. Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient. Transplantation 2000; 69:19561958.MEDLINE
  • 22
    Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001; 7:181190.MEDLINE
  • 23
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:13211324.MEDLINE
  • 24
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431435.MEDLINE
  • 25
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 19:14931499.
  • 26
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 19:14851492.
  • 27
    Telegdy L, Gorog D, Horanyi M, Schaff Z. Severe relapse of hepatitis C following liver transplantation. Successful treatment with a combination of interferon-alpha and ribavirin. Orv Hetil 1999; 140:18911893.MEDLINE
  • 28
    Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, Williams R. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27:14031407.MEDLINE
  • 29
    Wasserman R, Brau N, Hassanein T, Bini E, Sulkowski M, Dieterich D. Once weekly epoetin alfa increases hemoglobin and decreases ribavirin dose reductions among HCV-infected patients who develop anemia on ribavirin/interferon alfa 2b therapy [abstract]. Hepatology 2000; 32:833A.
  • 30
    de Vera ME, Smallwood GA, Rosado K, Davis L, Martinez E, Sharma S, et al. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation 2001; 71:678686.MEDLINE
  • 31
    Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995; 22:10841089.MEDLINE
  • 32
    Vargas V, Charco R, Castells L, Esteban R, Margarit C. Alpha-interferon for acute hepatitis C in liver transplant patients. Transplant Proc 1995; 27:12221223.MEDLINE
  • 33
    Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients [letter]. N Engl J Med 1994; 330:11601161.MEDLINE
  • 34
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773779.MEDLINE
  • 35
    Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28:831838.MEDLINE
  • 36
    Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali M, et al. Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination. Transplant Proc 1997; 29:519521.MEDLINE
  • 37
    Samuel D, Bizollon T, Feray C, Lemonnier C, Cohard M, Bismuth H, Trepo C. Combination of interferon alfa 2-B plus ribavirin for recurrent HCV infection after liver transplantation: A randomized controlled study [abstract]. Hepatology 2000; 32:542A.
  • 38
    Gotz G, Schon MR, Haefker A, Neuhaus R, Berg T, Hopf U, Neuhaus P. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin. Transplant Proc 1998; 30:21042106.MEDLINE
  • 39
    Willner IR, Chavin KD, Rogers J, Baliga P, Reuben A. Combination interferon-ribavirin is ineffective and poorly tolerated by liver transplant recipients with genotype 1 recurrent hepatitis C [abstract]. Hepatology 2000; 32:290A.